Results 51 to 60 of about 21,287 (236)
ADPKD is caused by pathogenic variants in PKD1 or PKD2, encoding polycystin-1 and -2 proteins. Polycystins are expressed in osteoblasts and chondrocytes in animal models, and loss of function is associated with low bone mineral density (BMD) and volume ...
Dalia Zubidat +19 more
doaj +1 more source
ADPKD, Tolvaptan, and Nephrolithiasis Risk [PDF]
Patients with autosomal dominant polycystic kidney disease (ADPKD) have a higher risk of nephrolithiasis ([1][1]). When using unenhanced computed tomography, calculi can be identified in up to 25% of patients with ADPKD ([2][2]).
Ewout J. Hoorn, Robert Zietse
openaire +3 more sources
Purpose: With evolving evidence around the progression, assessment, and management of autosomal dominant polycystic kidney disease (ADPKD), care of the disease has become increasingly complex.
M. Bevilacqua +6 more
doaj +1 more source
Cyst growth in ADPKD is prevented by pharmacological and genetic inhibition of TMEM16A in vivo
In autosomal dominant polycystic kidney disease (ADPKD) multiple bilateral renal cysts gradually enlarge, leading to a decline in renal function. Transepithelial chloride secretion through cystic fibrosis transmembrane conductance regulator (CFTR) and ...
Inês Cabrita +6 more
semanticscholar +1 more source
Measuring and estimating GFR and treatment effect in ADPKD patients: results and implications of a longitudinal cohort study. [PDF]
Trials failed to demonstrate protective effects of investigational treatments on glomerular filtration rate (GFR) reduction in Autosomal Dominant Polycystic Kidney Disease (ADPKD).
Buongiorno E +71 more
core +1 more source
Holger Schirutschke, Peter Gross, Alexander Paliege, Christian Hugo University Hospital Carl Gustav Carus at the Technische, Universität Dresden, Department of Internal Medicine III, Division of Nephrology, Dresden, GermanyCorrespondence: Holger ...
Schirutschke H +3 more
doaj
TAMEing ADPKD with metformin: safe and effective?
The biguanide metformin has been safely and widely used in the treatment of type 2 diabetes mellitus for decades. Preclinical studies have suggested that it may have a role in slowing disease progression in autosomal dominant polycystic kidney disease. In this issue, Perrone et al.
Ong, A.C.M., Gansevoort, R.T.
openaire +3 more sources
Molecular pathways involved in injury-repair and ADPKD progression.
The major hallmark of Autosomal Dominant Polycystic Kidney Disease (ADPKD) is the formation of many fluid-filled cysts in the kidneys, which ultimately impairs the normal renal structure and function, leading to end-stage renal disease (ESRD).
Chiara Formica, D. Peters
semanticscholar +1 more source
The final dilution of urine is regulated via aquaporin-2 water channels in the distal part of the nephron. It is unclear whether urine dilution ability in autosomal dominant polycystic kidney disease patients (ADPKD patients) differs from other patients ...
M. H. Malmberg +3 more
doaj +1 more source
PKD1 gene rs7185040 polymorphism and progression of chronic kidney disease in patients with ADPKD [PDF]
Introduction: Autosomal dominant polycystic kidney disease (ADPKD) is a commonly encountered genetic condition contributing to chronic renal failure in both pediatric and adult populations. Roughly 89% of individuals with ADPKD exhibit mutation in either
Aiswarya Kosaraju +3 more
doaj +1 more source

